友邦保險(01299.HK):董事會主席謝仕榮退任 由杜嘉祺於2025年10月1日接任
格隆匯6月6日丨友邦保險(01299.HK)發佈公告,獨立非執行主席及獨立非執行董事謝仕榮已知會董事會其退任公司職務的意向,自2025年9月30日起生效。
杜嘉祺(Sir Mark Tucker)已獲委任爲獨立非執行主席及獨立非執行董事(待監管批準),自2025年10月1日起生效,彼曾於2010年至2017年間擔任友邦保險集團首席執行官兼總裁。同時,杜嘉祺亦獲委任爲提名委員會主席及薪酬委員會成員,自2025年10月1日起生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.